Clinical Trials Directory

Trials / Unknown

UnknownNCT03010553

Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Fifty patients with squamous cell carcinoma of the larynx T1 or T2N0 will therefore have a 99mTc lymphoscintigraphy per operative. The identified sentinel node will be removed along with the other lymph nodes of the selective group II and III recess. Sentinel lymph node staging alone and complete dissection with routine anatomical pathology will be compared If this technique is reliable it will make a therapeutic de-escalation in the treatment of small tumors of the larynx by limiting the ganglionic gesture in the patients whose sentinel node is free from metastasis and also to better choose the treatment in case of lymph node involvement

Conditions

Interventions

TypeNameDescription
PROCEDUREDetection and resection of sentinel lymph node

Timeline

Start date
2008-02-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2017-01-05
Last updated
2017-01-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03010553. Inclusion in this directory is not an endorsement.